Teora
Teora is a Singapore-based biotech that designs AI-engineered, feed-based oral biologics (ShrimpGuard, FishGuard, FishJumbo, ShrimpTrident) for aquaculture disease management and growth enhancement, with planned expansion into livestock, poultry, and crops.
- Company typePrivate
- Founded2020
- HeadquartersSingapore, Singapore
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Teora does
Teora is a Singapore-headquartered biotech company that designs and delivers AI-engineered, feed-based oral biologics for animal disease management and growth enhancement. Its SOLAQ™ platform combines proprietary bioinformatics, synthetic biology, precision fermentation, and microencapsulation to produce room-temperature-stable, species-specific products that replace antibiotics, injections, and cold-chain-dependent vaccines across aquaculture, with planned expansion into livestock, poultry, crops, and companion animals.
The company sells its products under trademarked sub-brands including ShrimpGuard™ and FishGuard™ (prophylactic disease protection), FishJumbo™ (growth enhancement), and the ShrimpTrident™ family (therapeutic intervention against WSSV, Vibrio, EHP, and IMNV in shrimp). Field-validated across 5 Southeast Asian countries with 10+ independent trials, Teora reports outcomes of up to 90% survival in shrimp and fish, 70% antibiotic reduction, 20% faster growth, and 0.2–0.5 FCR improvement. The platform compresses biologic development cycles from 3–5 years to 6–8 months.
Teora generates revenue through transactional biologic product sales to aquaculture farmers, feed mills, and distributors, supplemented by licensing partnerships, co-development arrangements, and distributor/reseller margins. Pricing is quote-based and volume-tiered. The company is privately held and venture-backed, with disclosed funding of approximately ~$2.0–2.3M spanning grants (Temasek Foundation, The Liveability Challenge, Alberta Innovates), angel (Investible), VC (PeakBridge), and accelerator backing (Entrepreneur First, Berkeley SkyDeck, Hatch). Operations span Singapore HQ and a Bangalore, India field operations office supporting South Asia trials and partnerships.
Teora firmographics
Firmographics- Name
- Teora
- Legal name
- Teora Pte. Ltd
- Website
- https://teoralife.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Teora is a Singapore-based biotech that designs AI-engineered, feed-based oral biologics (ShrimpGuard, FishGuard, FishJumbo, ShrimpTrident) for aquaculture disease management and growth enhancement, with planned expansion into livestock, poultry, and crops.
- Ownership category
- akta.pro rank
Teora industry classification
Industry- Product category
- Aquaculture Biologics
- NAICS
- Other Animal Food Manufacturing (311119), Animal Food Manufacturing (3111)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Functional & Health Aquaculture Feed (Immunity, Disease Mitigation) (AFADADAI)
- akta.pro secondary industries
- Aquaculture Feed & Nutrition (HLAMAHAF), Carrier Systems & Microencapsulated Additive Premixes (Protected Nutrients, Slow-Release) (AFADAGAN), Broodstock & Breeder Feed (AFADADAF)
Keywords
Where Teora is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices2 records
Markets served
Teora business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Biologic Product Sales (Aquaculture): Sale of feed-based biologics (ShrimpGuard, FishGuard, FishJumbo, ShrimpTrident) to aquaculture farmers, feed mills, and distributors. Products are sold as top-coated feed additives or standalone powders. Revenue is transactional with recurring purchase dynamics driven by farm cycle needs.
- Licensing Partnerships: Teora offers licensing partnerships for its technology platform, enabling other companies to access SOLAQ™ biologics for specific species, regions, or applications.
- Co-Development & Custom Solutions: Custom biologic development partnerships with feed mills, distributors, or large farming operations requiring species or pathogen-specific solutions. Revenue generated through development fees and subsequent product supply.
- Distribution & Reseller Revenue: Revenue through distributor and reseller networks that stock and sell Teora biologics to end-user farmers, with margins earned on product throughput.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Volume-based pricing for smallholder and industrial farms |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
Teora product offering
Product offeringCore offering
Teora develops and manufactures disease management and growth enhancement solutions for aquaculture and livestock farming through its proprietary SOLAQ™ AI-powered biotech platform. The platform combines AI-driven bioinformatics, synthetic biology, precision fermentation, and advanced microencapsulation to produce feed-based oral biologics—multi-peptide and microRNA products applied as top-coated feed additives that replace antibiotics, traditional vaccines, and injection-based treatments. Core products include ShrimpGuard™, FishGuard™, FishJumbo™, and ShrimpTrident™ (with variants targeting WSSV, Vibrio, EHP, and IMNV pathogens), sold to shrimp and fish farmers, feed mills, and distributors.
Product overview
Teora offers SOLAQ™, an AI-powered biotech platform that delivers clean, feed-integrated biologics for disease management and growth enhancement across aquaculture, livestock, poultry, companion animals and agriculture. The platform is built around two core product lines: the GUARD SERIES (ShrimpGuard™ and FishGuard™) providing prophylactic disease protection, and the JUMBO SERIES (FishJumbo™) for growth optimization. Additionally, ShrimpTrident variants (SPOT, VIB, EH, MYO) provide targeted therapeutic interventions for specific shrimp pathogens. All products are feed-based, room-temperature stable, antibiotic-free, and designed for direct integration into existing farm operations.
Differentiator
Problem solved
Functional benefit
Brands
- ShrimpGuard: Feed-based multi-peptide biologic that primes shrimp innate immunity against viral and bacterial challenges including WSSV, IMNV. Available as ShrimpGuard Hatchery and ShrimpGuard Grow-out.
- FishGuard
- FishJumbo
- ShrimpTrident
Quantifiable outcome
- Up to 90% survival in shrimp farms (vs 0-30% untreated control)
- +11 more outcomes
Companies that use Teora
Customer profileNamed customers2 records
Segments6 records
Ideal customer profiles4 records
Teora technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature8 records
Teora partnerships and signals
Strategic signalScale indicators7 records
Recent moves2 records
Expansion highlights6 records
Teora competitors and assessment
Company assessmentDirect peers
- Phibro Animal Health: Phibro operates a dedicated aquaculture health portfolio (including vaccines and treatments for shrimp and fish pathogens) sold through similar B2B channels to integrators and feed mills. Teora competes most directly with Phibro's health products in SE Asian shrimp and fish farms.
- INVE Aquaculture (Benchmark Holdings): INVE offers health and nutrition products for aquaculture hatcheries and grow-out operations, including probiotics and disease-management solutions for shrimp and fish. Like Teora, INVE targets the same species and farm-vertical customers in SE Asia.
- Lallemand Animal Nutrition: Lallemand provides probiotics, yeast derivatives, and microbial feed additives across aquaculture and livestock, with comparable B2B feed-mill and farmer channel relationships. Teora's peptide and RNAi biologics are a higher-precision alternative to Lallemand's microbial solutions.
Emerging players
- Veramaris: Veramaris produces alternative, sustainable nutrition ingredients (algal omega-3) for aquaculture feed, addressing similar sustainability and residue-free positioning as Teora. Comparable in being a science-led, feed-based aquaculture solutions company targeting premium feed mills.
Broad incumbents
- Alltech: Alltech is a global animal nutrition and health company with aquaculture-specific products, including probiotics and feed additives. Teora competes for share of feed-mill biologics and species-specific solutions across the same customer base.
- Elanco Animal Health: Elanco is a global animal health giant with a substantial aquaculture portfolio including vaccines and therapeutics. As a large incumbent with established regulatory dossiers and distribution, Elanco represents the most credible large-player threat to Teora's positioning.
- Merck Animal Health (MSD Animal Health): Merck/MSD Animal Health is a global leader in aquaculture vaccines and health products. Comparable in targeting disease management in shrimp and fish but with established scale, capital, and regulatory reach that Teora must compete against.
- Virbac: Virbac is a global animal health company with aquaculture products spanning vaccines, anti-infectives, and nutrition. Comparable in targeting health outcomes in farmed species through veterinary biologics, but operating at much larger scale.
Others
- BioMar Group: BioMar is a major aquaculture feed manufacturer that increasingly incorporates health and functional ingredients into its feeds. BioMar is both a potential channel partner and a competitor for functional feed-additive share.
- Skretting (Nutreco): Skretting is the world's largest aquaculture feed producer with active development of functional and health-focused feed lines. Skretting represents both a major distribution channel opportunity and a potential competitor for premium feed positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Teora social profiles
Digital presenceTeora compliance and trust
Trust signalCompliance3 records
Teora financial estimates
Financial estimateRevenue estimate
Valuation estimate
Teora leadership team
Management profileNumber of profiles
Profiles5 records
Teora funding detail
Funding detailFunding overview
Funding rounds6 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Teora M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Teora
What does Teora do?
Teora develops and manufactures disease management and growth enhancement solutions for aquaculture and livestock farming through its proprietary SOLAQ™ AI-powered biotech platform. The platform combines AI-driven bioinformatics, synthetic biology, precision fermentation, and advanced microencapsulation to produce feed-based oral biologics—multi-peptide and microRNA products applied as top-coated feed additives that replace antibiotics, traditional vaccines, and injection-based treatments. Core products include ShrimpGuard™, FishGuard™, FishJumbo™, and ShrimpTrident™ (with variants targeting WSSV, Vibrio, EHP, and IMNV pathogens), sold to shrimp and fish farmers, feed mills, and distributors.
Is Teora a public or private company?
Teora is a private company. It is classified as venture growth investor backed and is currently operating.
When was Teora founded?
Teora was founded in 2020. It employs 11 to 50 people.
Where is Teora based?
Teora is headquartered in Singapore, Singapore, in the Asia region.
How does Teora make money?
Four revenue lines are on record. Biologic Product Sales (Aquaculture) is the primary driver. The others are licensing Partnerships, co-Development & Custom Solutions and distribution & Reseller Revenue.
Who are Teora's main competitors?
Direct peers on record are Phibro Animal Health, INVE Aquaculture (Benchmark Holdings) and Lallemand Animal Nutrition. Veramaris is listed as an emerging player. Broad incumbents are Alltech, Elanco Animal Health, Merck Animal Health (MSD Animal Health) and Virbac. Others are BioMar Group and Skretting (Nutreco).
Does Teora have an API?
No public API is recorded for Teora.
What industry is Teora in?
Teora's product category is Aquaculture Biologics. Its primary akta.pro industry code is AFADADAI, Functional & Health Aquaculture Feed (Immunity, Disease Mitigation), with a secondary code of HLAMAHAF, Aquaculture Feed & Nutrition. Its NAICS code is 311119 and its SIC code is 2836.